WEC
GHDX

Winslow Evans & Crocker’s Genomic Health, Inc. GHDX Stock Holding History

Winslow Evans & Crocker’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-336
Closed -$20K – 1184
2019
Q2 		$20K Hold
336
– – 0.01% 675
2019
Q1 		$24K Buy
336
+70
+26% +$5.19K 0.01% 633
2018
Q4 		$18K Hold
266
– – 0.01% 652
2018
Q3 		$20K Buy
266
+166
+166% +$9.71K 0.01% 671
2018
Q2 		$6K Buy
+100
New +$3.97K ﹤0.01% 940

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Winslow Evans & Crocker's GHDX Position: Q3 2019 in Review

Winslow Evans & Crocker sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 336 shares — an estimated $20K sold.

Winslow Evans & Crocker first reported a position in GHDX in Q2 2018 and held it in 5 quarters. The position peaked at $24K in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Winslow Evans & Crocker reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 336 Genomic Health, Inc. shares in Q3 2019, an estimated $20K.
  • Winslow Evans & Crocker first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 5 quarters.
  • Winslow Evans & Crocker's Genomic Health, Inc. position peaked at $24K in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Winslow Evans & Crocker's 13F filing for Q3 2019, filed 16 Oct 2019.